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osting by EAbstract Glycoconjugates are involved in the vital physiological functions including blood group
determination, cancer recognition, protein stabilization, sperm-egg adhesion and pathogenic inter-
action in body. These diverse biological functions of glycoconjugates are regulated by complex oli-
gosaccharide structures linked with proteins and lipids in macromolecular assemblies. The diversity
in oligosaccharide chains attached with lipids and proteins is speciﬁcally linked with the conforma-
tional behavior of sugar residues giving rise to unique carbohydrate structures with wide range of
sequence and anomeric linkage. This is a challenging task to explore the relationship between bio-
logical processes and stereochemical behavior of sugar residues. Current review article focuses the
speciﬁc stereochemical involvement (anomery and linkages) of Gal and its derivative GalNAc in
wide range of cellular activities. These sugar residues exhibit different physiological functions at
the terminal and subterminal position in glycans.
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Complex biomolecular assemblies carrying diverse glycan
chains are involved inwide range of pathological and physiolog-
ical activities. Diversity of glycan chains, linked to lipids and
proteins is due to isomeric and conformational modiﬁcations
of various sugar residues, giving rise to unique carbohydrate
structures with wide range of anomeric linkages. This unique
and signiﬁcant structural diversity of naturally occurring oligo-
saccharide structures make them best recognition markers for
countless physiological activities. Today the scientists (biochem-
ists, immunologists, molecular biologists, microbiologists,
pathologists and pharmacologists are doing tremendous effort
to explore the relationship of sugars with their glycobiology.
Glycoproteins and glycolipids are the major constituents of
biomembranes, regulating the wide range of cellular functions
including cellular differentiation, interaction and communica-
tion. In nature, approximately 90% of the glycosylated pro-
teins are N-linked having oligosaccharide chains attached
with Asn of parent protein structure. While in mucins (O-
linked glycoproteins, oligosaccharide chains are attached with
serine (Ser)/threonine(Thr) through GalNAc residue [1–7].
Sugar residues like D-galactose (Gal), N-Acetyl-D-galactos-
amine (GalNAc), D-glucose (Glc), N-Acetyl-D-glucosamine
(GlcNAc), N-acetyl neuraminic acid (NeuAc), fucose (Fuc)
and mannose (Man) are widely carried by glycolipids (GM1,
GD1a, GD1b, GT1b, GM2, GM3, GD2, GD3 and GT1c
gangliosides), glycoproteins, glycosylphosphatidylinositol-an-
chored (GPI-anchors) proteins andmany other glycoconjugates
[8–13]. Our main focus in this article is to relate the particular
structural features of Gal and GalNAc with their cellular
physiology.
The C-4 axial positioned hydroxyl group of Gal distin-
guishes it from glucose sugar (having equatorial OH group).
GalNAc, which is the derivative of Gal, contains N-acetyl
amine at C-2 position instead of OH group. This NHAc group
discriminates the GalNAc from the Gal sugar due to its charge
density and stereoelectronic conﬁguration. The changed phys-
iological behavior of GalNAc can be examined by the simple
example of ABO blood group system. The recognition of
blood group A is speciﬁcally linked with terminal GalNAc
(a1-3) in lacto series of oligosaccharide chain while the blood
group B variant is associated with Gal sugar terminally linked
with the oligosaccharide chain. So, the nature of sugar residue
is vitally important in cellular physiology [14,15].The modiﬁcations on Gal and GalNAc in the form of sul-
fation and methylation can change the total charge density,
change in enthalpy (DH), change in entropy (DS) of glycans,
which are speciﬁcally linked with alteration in various biolog-
ical processes [13,16–18].
Additionally, the involvement of anomery and linkage ofGal
andGalNAc in various biological activities are themain focus of
the article. The literature data and experimental evaluations de-
pict that the change in anomery and linkages cause the remark-
able alteration in biological functioning. Infact, the alteration in
physiological functions of glycans are speciﬁcally linkedwith the
sequence and anomeric linkages of sugarmolecules. The interac-
tion property of Artocarpus integrifolia lectin with terminal
aGal is themost common example in this context.A. integrifolia
has signiﬁcant binding potency for methylated a anomer
(Galb1-3GalNAcaMe) of T-antigen rather than its b anomer
(Galb1-3GalNAcbMe). This binding tendency is linked with
DH and DS values calculated for both beta and alpha anomers
of T-antigens. Similarly in ABH blood group system, blood
group H antigen is converted into blood group A determinant
by the terminal addition of GalNAc with speciﬁc anomeric link-
age (a1-3). And blood group B antigen is formed by the terminal
addition of Gala1-3 into H-antigen structure. So, we can say
that the Gal and GalNAc with particular stereochemical fea-
tures (anomery and linkage) are providing structural basis for
wide range of cellular phenomena [13–18].
2. Role of sequence, linkage and anomery of Gal and GalNAc in
various pathological activities
Carbohydrates carrying Gal and GalNAc residues are most
common receptors for microbial infections like gonorrhoeae
[19], sleeping sickness [20], meningitis [21], diarrhea [22], pneu-
moniae [23] and inﬂuenza [24]. Glycan–protein interaction is
one of characteristic features of microbial adhesion. A micro-
bial ligand exhibits different binding potency for the microbial
isoreceptors due to alteration in stereochemical conformations.
For example, Propioni granulosum (P. granulosum) is a normal
human skin bacterium, while Neisseria gonococcus (N. gono-
coccus) is the gonorrheae pathogen. Both bacteria recognize
the lactosylceramide motif (Gal b1-4 Glc1-1Cer), but have dif-
ferent speciﬁcity for isoreceptors. It is also perceived from
experimental data that the P. granulosum has strong binding
preference for glycolipids of lacto and neo-lacto series, but
the N. gonococcus has weak binding potency for these series
Role of Gal and GalNAc containing glycans in various physiological processes 3[25]. Literature data has also proved that the terminal addition
of Fuc into lactosylceramide motifs, inhibit the biding ten-
dency of these bacteria. But if the Gala residue is introduced
at position C-3, the poor adhesion property is observed.
Another example of microbial disorder is the sleeping sick-
ness, which is regulated by protozoan parasite, Trypanosoma
brucei in humans. This parasite contains Gala1-3Gal disaccha-
ride domain on glycoprotein chain [20].
Streptococcus suis (S. suis) is another pathogen which has its
involvement in development of neural disorders like stroke, neu-
ral tumor and meningitis. The cellular interaction between neu-
ral tissue and meningitis-causing bacteria (like S. suis) is
mediated by the Gal containing oligosaccharide structure (as
shown in Fig. 1). Gala1-4Gal is themost preferable disaccharide
for potent binding interaction of S. suis with the host cells [21].
Shiga toxins having two major groups Stx1 (Shigella
dysenteriae type 1) and Stx2, specially bind to galabiose por-
tion of glycans. The literature study tells that the glycolipids
deﬁcient with galabiose sequences do not bind with shiga tox-
in. It is also observed that the majority of the glycolipids with
internally positioned galabiose (Gala1-4Gal) are found inac-
tive for shiga toxin binding. These intermolecular interactions
are regulated between microbial and host body due to hydro-
xyl groups of sugar residues (Gal and GalNAc) [22–25].
Entamoeba histolitica (E. histolitica) is the causative agent of
water born diseases. The favourable anomeric linkages for
binding interaction of that pathogen are Galb1-4 or Galb1-3.
The experimental study highlights that the removal of terminal
Gal can affect the binding tendency of E. histolitica. Similarly,
the terminal Gal with a1-4 linkage is found dynamic binding
receptor for Escherichia coli (E. coli) interaction with human
uroepithelial cells [26–28].
Additionally, the fabry disease is linked with the accumula-
tion of glycolipids having Gal moiety with a anomery. The
gathering of two such glycosphingolipids is detected in urine,
blood plasma and other tissues of fabry’s patient [29].Figure 1 Intramolecular and intermolecular hydrogen bonding
between the Streptococcus suis and disaccharide epitope.More advancement in cancer development has shown that
the cancer markers like CA19-9 and CA125 behave as pointers
for colorectal and ovarian cancers, respectively [30].
3. Lectins and glycan chemistry
Lectins, the N-linked glycoproteins are involved in several
important physiological phenomena like cell death, immune
system homeostasis, cancer phagocytosis and control of tumor-
igenesis. All the lectins, having same nature as that of Iris lectin
can be discriminated on the basis of their interactions with de-
tailed carbohydrate structures. For example, Peanut agglutinin
(PNA) and Amaranthin speciﬁcally characterize the T-antigen
disaccharide (Gal b1-3GalNAc) structure, while the Lima bean
lectin (LBL) has strong binding potency for the blood group A
trisaccharide unit. The strong binding speciﬁcity of Iris lectin
for disaccharide motifs like GalNAca1-3Gal and GalNAca1-
6Gal reﬂects the physiological signiﬁcance of oligosaccharide
chains as compared to monosaccharaides. These observations
highlight that the lectins have an extensive carbohydrate bind-
ing domain, complementary to GalNAc residue. The literature
study elucidates that theN-acetyl group (equatorial position) at
the C-2 of GalNAc is the main functional group, which
enhances the binding of GalNAc to the lectin. So, the GalNAc
more effectively bind with the lectins as compared to Gal. Both
the Forssman dissacharide and blood group A trisaccharide
determinants are poor binders for Iris lectin and their interac-
tion speciﬁcity for lectins proposes that the hydroxyl group at
C-2 of penultimate Gal is the vital locus for the lectin binding.
The poor binding tendency of Iris lectin with Forssman dissa-
charide is due to the steric hindrance of N-acetyl group present
on the penultimate Gal residue [4].
Similarly, the leguminous plant Dolichos biﬂorus lectin
(DBL) has signiﬁcant binding speciﬁcity for GalNAc as com-
pared to the Gal. It is perceived from reported data that theFigure 2 Complex of Dolichos Biﬂorus Seed Lectin with the
Blood Group A trisaccharide [5–6].
4 M.R.M. Hussain et al.complexation of blood group A and H variants with DBL is
affected by blood group A trisaccharide epitope. The compar-
ative study of DBL-Forssman complex and blood group A
(trisaccharide)-DBL complex shows that the binding regions
have low afﬁnity for Gal as compared to GalNAc (Fig. 2).
DBL has a powerful speciﬁcity of binding for GalNAc because
the N-acetyl group gives compensation for the loss of aromatic
stacking in DBL by creating the hydrogen bonding with the
back chain amide group of Gly103 [5–6].O
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the blood group A, B, H and Lewis blood group antigens.
Table 1 Glyco-epitopes and their involvement in various physiological activities.
Glycan ID/name Epitope structure Physiological context and references
EP0255/blood group A trisaccharide GalNAc(a1-3)(Fuc(a1-2))Gal(b1-3)SGlcNAc(b1-)-R Characterization of ABH blood group antigens into diﬀerent
mammalian tissues and recognition of normal and cancer cells [14–15,31]
EP0256/blood group A type 1 GalNAc(a1-3)(Fuc(a1-2))Gal(b1-3)GlcNAc(b1-)-R Expression of Blood group A types in columnar cells of normal fetal
mucosa [14–15,31]
EP0260/blood group A type 1
(difucosyl or A Leb)
GalNAc(a1-3)(Fuc(a1-2))Gal(b1-3)(Fuc(a1-4))GlcNAc(b1-)-R Localization of goblet cells of normal fetal mucosa [14–15]
EP0257/blood group A type 2 GalNAc(a1-3)(Fuc(a1-2))Gal(b1-4)GlcNAc(b1-)-R Adenocarcinomas [14–15]
EP0261/blood group A type 2
(difucosyl)
GalNAc(a1-3)(Fuc(a1-2))Gal(b1-4)(Fuc(a1-3))GlcNAc(b1-)-R Recognition of normal goblet cells and colon cancer [14–15]
EP0262/blood group B type 2 Gal(a1-3)(Fuc(a1-2))Gal(b1-4)GlcNAc(b1-)-R Recognition of Fabry’s disease [29]
EP0258/blood group A type 3 GalNAc(a1-3)(Fuc(a1-2))Gal(b1-3)GalNAc(a1-)-R Detection of columnar cells of normal fetal mucosa, human cervical
epidermal cancer, bladder and colon cancer [33]
EP0047/Asialo-GM1 GalNAc(a1-3)(Fuc(a1-2))Gal(b1-)-R OR Gal(b1-3)
GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
Recognition of small cell lung carcinoma (SCLC) cell lines and antibody
interactions [34–38]
EP0093/Dimeric Lewis x Gal(b1-4)(Fuc(a1-3))GlcNAc(b1-3)Gal(b1-4)(Fuc(a1-3))GlcNAc(b1-)-R Human cancer and fucosidosis [39–40]
EP0037/Forssman antigen GalNAc(a1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer Cestode serological cross-reactivity and interaction with embryonal
carcinoma cells (ECC) [41–42]
EP0059/GD1 Gal(b1-3)GalNAc(b1-4)(Neu5Ac(a2-8)Neu5Ac(a2-3))
Gal(b1-4)Glc(b1-1)Cer
1. Localization of central and peripheral nervous system [11–12]
2. Prostate cancer marker [43]
EP0061/GD2 GalNAc(b1-4)(Neu5Ac(a2-8)Neu5Ac(a2-3))Gal(b1-4)Glc(b1-1)Cer 1. Targeting of lung carcinoma [44]
2. Human neuroectodermal tumor cells and gliomas [45]
H00218 Gal b (1-4)GlcNAc b (1-6))Gal b (1-3)
GalNAc And Galb1-3GlcNAcb1-3GalNAc
1. Cystic ﬁbrosis [46]
2. Bronchiectasis [47]
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6 M.R.M. Hussain et al.group antigens are biologically signiﬁcant because these
epitopes mediate the genetical and biochemical speciﬁcities on
the red blood cells. Blood group H antigen is the precursor
for blood group A, B and Leb antigens (Fig. 3). The blood
group A determinants have the different epitopic domains of
lacto-series. Blood group A type 1 structure is highly expressed
in goblet and columnar cells of normal fetal mucosa, while the
type 2 chains are accumulated in the human colon carcinomas.
The glyco-epitopes of type 1 and 2 chains of blood group A dif-
fer only in their anomeric linkages at fucosylated Gal residues
and this difference may provide the structural basis for their
localization in normal and carcinomal cells. It can also be pre-
dicted from this example that the cellular characterization of
normal and carcinomal tissues is speciﬁcally linked with the
anomeric linkages of sugar residues [14,15,31–33]. Further
elaboration about the implication of Gal and GalNAc
containing epitopes in different biological processes is given
in Table 1.
Similarly, the glycan study of fertilization process elucidates
that the nature and sequence of the sugar residues are valuable
tools for preventing the unintended pregnancy in mammals.
Free-swimming sperms have signiﬁcant adhesion speciﬁcity
for O-linked glycoproteins (mZP1, mZP2 and mZP3) of zona
pellucida. After binding interaction of sperms with the carbo-
hydrate epitopes, sperms undergo the cellular exocytosis and
acrosomal reaction which enable the sperms to penetrate the
zona pellucid for fertilization. These male and female gametes
interact with each other through Gal and GalNAc containing
glycans and hence mediate the fertilization. Several parameters
like the size, branching pattern and nature of the sugar resi-
dues are creating interruptions in sperm-egg interaction pro-
cess. Two trisaccharides (Galb1-4GlcNAcb1-4GlcNAc) and
(Gala1-3Galb1-4GlcNAc)) having Galb1-4 and Gala1-3 at
their terminal ends are found important for inhibiting the
sperm-egg adhesion with moderate afﬁnity. While the addition
of fucose residue in these two trisaccharides, produce the high
afﬁnity for the sperm-egg binding [48–49].5. Effect of modiﬁcations (sulfation and methylation) in
biological processes
Modiﬁcations like sulfation and methylation on Gal and
GalNAc are linked with remarkable physiological functions
including, regulation of cell growth, myelinisation, neuronal
plasticity, pathogenic binding and characterization of cystic
ﬁbrosis and bronchitis [16,50–53]. e.g. The pathogenic adhesion
ofMycoplasma pneumonia (M. pneumonia) occurs due to sulfate
group at terminal Gal(b1-4). It is also observed that the removal
of sulfate group affect the binding property of M. pneumonia
with glycolipids. Similarly, the glycans having sulfate group at
the C-3 and C-6 of Gal are involved in the characterization of
different diseases like cystic ﬁbrosis and bronchitis. SM3 and
SM4 are sulfated glycolipids having their involvement in colon
and hepatocellular carcinoma. The removal of sulfated SM4
has been documented with the inhibition of metastasis. Addi-
tionally, Sulfatide, a 3-O-sulfo galactosylceramide abundantly
exists in myelin tissues and mediates the diverse range of phys-
iological phenomena like neuronal plasticity, myelinisation,
protein trafﬁcking, signal transduction and morphogenesis.
Methylation is the second type of modiﬁcation on Gal and
GalNAc, which has its speciﬁc physiological role in lectinbinding or recognition process [23,46–53]. Physiological
efﬁcacy of these modiﬁcations and their association in various
cellular phenomena are given below.
5.1. Physiological signiﬁcance of sulfated Gal and GalNAc
Sulfated glycoconjugates occur in large variety of biological
systems, in the form of glycoproteins, proteoglycans, glycolip-
ids, and polysaccharides. The negative ionic potential of
sulfate group is considered as a strong sticking force for wide
range of glycans, which regulate vital physiological activities
like cellular growth, adhesion, modiﬁcation and communica-
tion in body.
In case of Gal, the attachment of sulfate group mostly
occurs at C-3 and C-6, while in case of GalNAc this attach-
ment occurs at C-4. The sulfoglycolipids like (3-sulfo-Lea)
and (3-sulfo Lex) have strong ligand binding for both E- and
L-selectins as compared to 3-sialylated derivatives of Lewisa
(Lea) and Lewisx(Lex). The expression of 3-sulfo-Lewisa epi-
tope decreases with increasing the level of invasion of colonic
carcinomas. While 3-SO3-Le
a and 3-SO3-Le
x determinants
are also linked with the recognition of various carcinoma
and nonmalignant epithelia [18,48–51].
The study of sulfated glycans shows that the sulfatedGal and
GalNAc are engaged in recognition and progression of many
carcinomas. Sulfated carbohydrate structures are also localized
in the airway mucins, secreted by patients of bronchitis and
cystic ﬁbrosis [52–53]. Glycans in cystic ﬁbrosis contain the
Gal b1-3 moiety with sulfate group at the C-6. These glycans
with the disaccharide (6Sulfated)Galb1-3GalNAc, trisaccharide
(6Sulfated)Galb1-3GlcNAcb1-3GalNAc, tetrasaccharide (6Sul-
fated)Galb1-4GlcNAcb1-3Galb1-3GalNAc and pentasaccha
ride (6Sulfated)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3GalNAc
structures are studied byMawhinney et al., in 1987 [46]. But the
fucosylated glycans in chronic bronchitis have sulfate moiety at
the C-3 of Gal b1. Sulfated Gal in sulfatides is oligodendrocyte
marker present inmyelin sheet of adult brain. Sulfatides are also
present in the form of seminolipids in the spermatogenic cells.
The abnormities in paranordal junction, myelinisation process
and prevention of neuronal degenerescence are also linked with
the sulfatides. The literature data elaborates that the large de-
crease in sulfatide concentrationmediates the Alzheimer disease
with mild dementia [16,46–53].
Additionally, the sulfated glycans have prominent adhesion
capacity for M. pneumoniae. This pathogen (M. pneumoniae)
cannot distinguish between the 3-sulfogalactosylceramide and
its 6-sulfo isoform. The terminal Gal(3SO4) b1- residues are
the main receptors for adhesion ofM. pneumoniae with glyco-
lipids while in case of glycoproteins, the pathogenic binding
takes place through NeuAca2-3Galb1-4GlcNAc motifs. These
results corroborate that the sulfate group with at least Gal
moiety in glycolipids is necessary for binding with the
M. pneumoniae [23].
Additional detail about the physiological functions of
sulfated glycans is given in Table 2.
5.2. Methylated Gal and GalNAc
Methylation is another type of sugar modiﬁcation which inﬂu-
ences the physical and chemical properties of glycans in macro-
molecular assemblies. Methylated glycans occur on lipids and
proteins and are involved in various cellular activities like
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Role of Gal and GalNAc containing glycans in various physiological processes 7cellular interaction, signaling and development. The simple
example discussed to evaluate the implication of methylated is
the recognition of Artocarpus integrifolia (A. integrifolia) lectin.
Artocarpus integrifolia lectin has strong binding interactions for
MeaGal and MeaGalNAc motifs (3). A. integrifolia has
signiﬁcant binding potency for methylated a anomer (Galb1-
3GalNAcaMe) of T-antigen rather than its b anomer (Galb1-
3GalNAcbMe). This binding tendency is linked with DH and
DS values calculated for both beta and alpha anomers of T-anti-
gens. Alpha anomer has strong binding interaction due to its
high DH, which overshadow the DS inﬂuence. The association
constant (Ka) values of disaccharides having aGal moiety are
found lower than that calculated for the MeaGal. Literature
study highlights that the removal of apolar methyl group in
MeaGal cause the weakening of lectin binding with the resulting
disaccharides (Gala1-3Gal and Gala1-3GalaMe). As the DG
and DH for both disaccharide motifs (Gala1-3Gal and Gala1-
3GalaMe) are same, but lower in case of MeaGal binding.
Therefore it can be concluded that the lectin interaction takes
place through terminal end of methylated glycans [13].6. Databases annotation
Different glycan databases like Kegg database, Glycoepitope,
Glycosuite, Glycome DB, Complex Carbohydrate Structural
Database (CCSD), GlycoMaps, Glycobase and Glycoscience
database are publicly present to evaluate the implications of
sugar anomeric linkages in speciﬁc recognition activities serv-
ing as a tool for the therapy of cancer and other fatal diseases.
These databases provide the information about glycan struc-
tures and their functional diversity, but are still limited about
the structure-function relationship of sugar motifs.
Kegg: Kyoto Encyclopedia of Genes andGenomes database
(http://www.genome.jp/kegg/) contains 10969 glycan entries
some of which are methylated, phosphorylated and sulfated.
Kegg database give information about structural ID, Composi-
tion, Mass, Structure, Class, biosynthetic pathway, orthology,
enzyme details and KCF data of glycan chains. Each Kegg gly-
can entry starts with Alphabetical letter G.
Glycoepitope: Glycoepitope database (http://www.glyco.is.
ritsumei.ac.jp/epitope/) has 146 glycoepitope entries. Each
epitopic ID starts with English Capital letter EP. The informa-
tion given against each entry contain data like Epitope ID,
Sequence, Aliases, History, Molecular weight, Species, compo-
sitions and receptor explanation.
EURO Carb DB: EURO Carb database (www.euro-
carbdb.org) consists of 13,457 unique glycan sequences of
which 1 HPLC, 89 Mass Spectrometry, and 0 NMR analyses
based structures are present.
Glycoscience: Glycoscience database (http://www.glyco-
sciences.de/index.php) gives detail about structures, Theoreti-
cal Mass peaks, NMR Data, Taxonomy etc. This database
contains 14857 different sugar structures having O-glycans
(505), N-glycans (3415), and glycolipids (560).
GB: GlycoBase contains information about 350 glycans of
which 117 glycans are human serum glycome. GlycoBase is a
relational database having HPLC data of glycans (http://gly-
cobase.ucd.ie, http://glycobase.univ-lille1.fr/).
CFG: Consortium for Functional Glycomics (www.func-
tionalglycomics.org) database contains nearly 7500 entries.
Each entry contains structural and chemical informations.
8 M.R.M. Hussain et al.BCSDB: Bacterial Carbohydrate Structure Database
(http://www.glyco.ac.ru/bcsdb3/) currently contains 9506
structures. Each entry contains BCSDB ID, Bibliography,
(Sub) structure, Microorganism, NMR signals data.
Glycome DB: Glycome database (http://www.glycome-
db.org/showMenu.action?major=database) gives information
about Image of structure and their units.
7. Conclusion
Oligosaccharide structures are playing variety of roles in health
and diseases. The signiﬁcance of Gal and GalNAc containing
epitopes in immunology, oncology and virology has been ex-
pressed in several experimental evaluations. However many
questions are still present, such as the importance of anti-
Gal antibody. This clearly highlights the need to amplify the
current efforts to interpret the roles of Gal and GalNAc epi-
topes in normal and abnormal conditions in body. Addition-
ally, the penultimate sugar residues attached with (speciﬁc
linkages and anomery) Gal and GalNAc are also vitally
important to provide physiological diversity by means of pos-
sible range of anomeric linkages. The current research article is
an impetus for the scientists especially for young researchers to
further interpret the memory capability of complex glycan
structures, with the aim of designing the vital therapeutic ele-
ments for the cancer and various other diseases.Acknowledgement
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